CLINICAL_TRIALS
trial_result
· 2020-12-17
Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin [Phase 2]
Summary
Phase 2 trial of antineoplaston therapy in unknown primary carcinoma was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Burzynski Research Institute | Conditions: Unknown Primary Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2020-12-17